Cardiac Resynchronization Therapy Remote Monitoring - COVID-19 Pandemic Experiences and Future Perspectives

Joanna Popiolek-Kalisz1, Grzegorz Kalisz2

  • 1Department of Cardiology, Cardinal Wyszynski Hospital, Lublin, Poland.

Insights

Remote monitoring for cardiac resynchronization therapy (CRT) in heart failure (HF) patients proved beneficial during COVID-19 lockdowns. This approach enhances patient care and device management through continuous surveillance and early clinical decision-making.

Area of Science:

  • Cardiology
  • Medical Technology
  • Digital Health

Background:

  • Cardiac resynchronization therapy (CRT) treats heart failure (HF) patients with left ventricle dyssynchrony.
  • Remote monitoring offers continuous patient and device surveillance, complementing in-office care.
  • The COVID-19 pandemic accelerated the adoption and evaluation of remote monitoring systems.

Purpose of the Study:

  • To summarize global experiences with CRT remote monitoring during the COVID-19 pandemic.
  • To highlight future potential applications of remote monitoring for CRT patients with HF.

Main Methods:

  • Systematic review of published literature on CRT remote monitoring during COVID-19 restrictions.
  • Analysis of experiences and outcomes reported in existing studies.

Main Results:

  • Published data confirm the advantages of telemedical approaches in managing CRT patients.
  • Remote monitoring facilitated timely clinical decisions and maintained patient surveillance during pandemic-related restrictions.

Conclusions:

  • Remote monitoring is a valuable tool for managing heart failure patients undergoing CRT.
  • Further research and publications are needed to fully understand the long-term impact and optimize remote monitoring strategies for CRT.

Related Concept Videos

Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
1.0K
Holter Monitor: 24-Hour Monitoring01:23

Holter Monitor: 24-Hour Monitoring

Holter monitoring is a continuous electrocardiography (ECG) recording that tracks the heart's electrical activity over an extended period, generally 24 to 48 hours. This noninvasive diagnostic tool detects irregular heart rhythms that may not be captured during a standard ECG performed in a clinical setting.DeviceThe Holter monitor is a portable, small device connected to several electrodes on the patient's chest. These electrodes detect the heart's electrical signals and transmit them to the...
669
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
99
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
117
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
111
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
114